O	0	1	A
O	2	12	comparison
O	13	15	of
B-Diagnostic_tool	16	28	stereoscopic
I-Diagnostic_tool	29	40	fluorescein
I-Diagnostic_tool	41	52	angiography
O	53	57	with
B-Diagnostic_tool	58	69	indocyanine
I-Diagnostic_tool	70	75	green
I-Diagnostic_tool	76	92	videoangiography
O	93	95	in
B-Disease	96	99	age
I-Disease	99	100	-
I-Disease	100	107	related
I-Disease	108	115	macular
I-Disease	116	128	degeneration
O	128	129	.

O	131	133	To
O	134	143	correlate
O	144	152	features
O	153	155	of
B-Diagnostic_tool	156	167	indocyanine
I-Diagnostic_tool	168	173	green
I-Diagnostic_tool	174	175	(
I-Diagnostic_tool	175	178	ICG
I-Diagnostic_tool	178	179	)
I-Diagnostic_tool	180	196	videoangiography
O	197	201	with
B-Diagnostic_tool	202	208	stereo
I-Diagnostic_tool	209	213	film
I-Diagnostic_tool	214	225	fluorescein
I-Diagnostic_tool	226	237	angiography
O	238	239	(
B-Diagnostic_tool	239	241	FA
O	241	242	)
O	243	245	in
O	246	249	the
O	250	258	analysis
O	259	261	of
B-Disease	262	265	age
I-Disease	265	266	-
I-Disease	266	273	related
I-Disease	274	281	macular
I-Disease	282	294	degeneration
O	295	296	(
B-Disease	296	299	AMD
O	299	300	)
O	300	301	.

O	302	303	A
O	304	317	retrospective
O	318	323	study
O	324	328	with
O	329	339	concurrent
O	340	350	comparison
O	351	353	of
O	354	357	two
O	358	365	methods
O	366	368	of
O	369	379	assessment
O	380	382	on
O	383	386	one
O	387	390	set
O	391	393	of
O	394	402	patients
O	403	407	with
B-Disease	408	411	AMD
O	412	422	undergoing
O	423	433	sequential
B-Diagnostic_tool	434	436	FA
O	436	437	-
B-Diagnostic_tool	437	440	ICG
I-Diagnostic_tool	441	457	videoangiography
O	457	458	.

O	459	462	One
O	463	470	hundred
O	471	475	four
O	476	484	patients
O	485	489	with
B-Disease	490	493	AMD
O	494	497	who
O	498	501	had
O	502	511	undergone
O	512	523	immediately
O	524	534	sequential
B-Diagnostic_tool	535	537	FA
O	537	538	-
B-Diagnostic_tool	538	541	ICG
I-Diagnostic_tool	542	558	videoangiography
O	559	563	were
O	564	572	selected
O	573	575	in
O	576	577	a
O	578	589	consecutive
O	590	597	fashion
O	598	602	from
O	603	606	the
O	607	619	photographic
O	620	625	files
O	626	628	of
O	629	632	the
O	633	638	Casey
O	639	642	Eye
O	643	652	Institute
O	652	653	.

O	654	659	Three
O	660	672	interpreters
O	673	686	independently
O	687	693	graded
O	694	696	in
O	697	699	an
O	700	708	unbiased
O	709	716	fashion
O	717	720	the
B-Characteristic	721	723	FA
I-Characteristic	724	732	features
O	733	735	of
B-Disease	736	739	AMD
O	739	740	.

O	741	746	These
O	747	751	were
O	752	760	compared
O	761	765	with
B-Characteristic	766	769	ICG
I-Characteristic	770	786	videoangiography
I-Characteristic	787	795	features
O	796	798	of
B-Characteristic	799	814	hypocyanescence
O	815	816	(
B-Characteristic	816	819	ICG
I-Characteristic	820	836	videoangiography
I-Characteristic	837	853	hypofluorescence
O	853	854	)
O	854	855	,
B-Characteristic	856	864	moderate
I-Characteristic	865	867	or
I-Characteristic	868	875	intense
I-Characteristic	876	892	hypercyanescence
O	893	894	(
B-Characteristic	894	897	ICG
I-Characteristic	898	914	videoangiography
I-Characteristic	915	932	hyperfluorescence
O	932	933	)
O	933	934	,
O	935	937	or
B-Characteristic	938	945	absence
I-Characteristic	946	948	of
I-Characteristic	949	961	fluorescence
I-Characteristic	962	966	over
I-Characteristic	967	977	background
O	978	979	(
B-Characteristic	979	982	ICG
I-Characteristic	983	999	videoangiography
I-Characteristic	1000	1014	isocyanescence
O	1014	1015	)
O	1015	1016	.

O	1017	1019	We
O	1020	1024	also
O	1025	1033	assessed
B-Characteristic	1034	1037	ICG
I-Characteristic	1038	1054	videoangiography
I-Characteristic	1055	1063	features
O	1064	1066	in
O	1067	1070	the
O	1071	1079	opposite
B-Anatomy	1080	1083	eye
O	1084	1086	of
O	1087	1092	those
O	1093	1097	with
B-Symptom	1098	1107	choroidal
I-Symptom	1108	1126	neovascularization
O	1127	1128	(
B-Symptom	1128	1131	CNV
O	1131	1132	)
O	1133	1135	by
B-Diagnostic_tool	1136	1138	FA
O	1139	1141	in
O	1142	1145	one
B-Anatomy	1146	1149	eye
O	1150	1152	by
O	1153	1162	examining
O	1163	1165	an
O	1166	1176	additional
O	1177	1179	96
B-Diagnostic_tool	1180	1182	FA
O	1182	1183	-
B-Diagnostic_tool	1183	1186	ICG
I-Diagnostic_tool	1187	1203	videoangiography
O	1204	1209	scans
O	1209	1210	.

O	1211	1219	Outcomes
O	1220	1224	were
O	1225	1228	the
B-Diagnostic_tool	1229	1232	ICG
I-Diagnostic_tool	1233	1249	videoangiography
O	1250	1265	characteristics
O	1266	1268	of
B-Symptom	1269	1276	classic
I-Symptom	1277	1280	and
I-Symptom	1281	1287	occult
I-Symptom	1288	1291	CNV
O	1291	1292	,
B-Symptom	1293	1299	serous
I-Symptom	1300	1307	pigment
I-Symptom	1308	1318	epithelial
I-Symptom	1319	1330	detachments
I-Symptom	1331	1332	(
I-Symptom	1332	1337	SPEDs
I-Symptom	1337	1338	)
I-Symptom	1339	1343	both
I-Symptom	1344	1348	with
I-Symptom	1349	1352	and
I-Symptom	1353	1360	without
I-Symptom	1361	1364	CNV
O	1364	1365	,
B-Symptom	1366	1373	macular
I-Symptom	1374	1384	hemorrhage
O	1384	1385	,
O	1386	1389	and
O	1390	1393	the
O	1394	1405	comparative
O	1406	1410	size
O	1411	1413	of
O	1414	1419	these
O	1420	1428	features
O	1428	1429	.

O	1430	1435	There
O	1436	1440	were
O	1441	1443	25
B-Anatomy	1444	1448	eyes
O	1449	1453	that
O	1454	1457	had
O	1458	1469	significant
B-Symptom	1470	1477	macular
I-Symptom	1478	1488	hemorrhage
O	1489	1491	by
B-Diagnostic_tool	1492	1494	FA
O	1494	1495	.

O	1496	1498	Of
O	1499	1504	these
O	1504	1505	,
O	1506	1509	the
B-Diagnostic_tool	1510	1512	FA
O	1513	1521	revealed
B-Symptom	1522	1525	CNV
O	1526	1528	in
O	1529	1532	its
O	1533	1541	entirety
O	1542	1547	under
O	1548	1550	or
O	1551	1555	near
O	1556	1559	the
B-Symptom	1560	1570	hemorrhage
O	1571	1573	in
O	1574	1576	11
O	1576	1577	.

O	1578	1581	The
B-Diagnostic_tool	1582	1585	ICG
O	1586	1597	examination
O	1598	1606	revealed
O	1607	1610	all
O	1611	1613	11
O	1614	1618	plus
O	1619	1621	an
O	1622	1632	additional
O	1633	1635	12
B-Characteristic	1636	1651	hypercyanescent
I-Characteristic	1652	1660	features
O	1661	1665	that
O	1666	1670	were
O	1671	1674	not
O	1675	1682	visible
O	1683	1685	by
B-Diagnostic_tool	1686	1688	FA
O	1688	1689	.

O	1690	1698	Although
O	1699	1701	26
O	1702	1704	of
O	1705	1707	32
B-Symptom	1708	1713	SPEDs
O	1714	1717	had
B-Symptom	1718	1721	CNV
O	1722	1724	by
B-Diagnostic_tool	1725	1727	FA
O	1728	1736	analysis
O	1736	1737	,
O	1738	1740	31
O	1741	1743	of
O	1744	1746	32
O	1747	1750	had
O	1751	1755	well
O	1755	1756	-
O	1756	1763	defined
B-Characteristic	1764	1780	hypercyanescence
O	1781	1786	under
O	1787	1789	or
O	1790	1792	at
O	1793	1796	the
B-Symptom	1797	1801	SPED
O	1802	1806	edge
O	1807	1809	by
B-Diagnostic_tool	1810	1813	ICG
I-Diagnostic_tool	1814	1830	videoangiography
O	1830	1831	.

O	1832	1838	Eighty
O	1838	1839	-
O	1839	1844	seven
O	1845	1852	percent
O	1853	1855	of
B-Anatomy	1856	1860	eyes
O	1861	1865	with
B-Symptom	1866	1873	classic
I-Symptom	1874	1883	choroidal
I-Symptom	1884	1895	neovascular
I-Symptom	1896	1905	membranes
O	1906	1907	(
B-Symptom	1907	1911	CCNV
O	1911	1912	;
O	1913	1915	20
O	1916	1918	of
O	1919	1921	23
O	1921	1922	)
O	1923	1926	and
O	1927	1929	93
O	1929	1930	%
O	1931	1933	of
B-Anatomy	1934	1938	eyes
O	1939	1943	with
B-Symptom	1944	1957	fibrovascular
I-Symptom	1958	1965	pigment
I-Symptom	1966	1976	epithelial
I-Symptom	1977	1988	detachments
O	1989	1990	(
B-Symptom	1990	1995	FVPED
O	1995	1996	;
O	1997	1999	66
O	2000	2002	of
O	2003	2005	71
O	2005	2006	)
O	2007	2011	were
B-Characteristic	2012	2027	hypercyanescent
O	2028	2032	with
O	2033	2041	distinct
O	2042	2047	edges
O	2047	2048	.

O	2049	2054	Fifty
O	2055	2062	percent
O	2063	2065	of
B-Anatomy	2066	2070	eyes
O	2071	2075	with
O	2076	2080	only
B-Symptom	2081	2085	late
I-Symptom	2086	2093	leakage
I-Symptom	2094	2096	of
I-Symptom	2097	2109	undetermined
I-Symptom	2110	2116	source
O	2117	2118	(
B-Symptom	2118	2122	LLUS
O	2122	2123	)
O	2124	2128	were
B-Characteristic	2129	2144	hypercyanescent
O	2144	2145	,
O	2146	2153	whereas
O	2154	2156	50
O	2156	2157	%
O	2158	2162	were
B-Characteristic	2163	2176	isocyanescent
O	2177	2179	on
B-Diagnostic_tool	2180	2183	ICG
I-Diagnostic_tool	2184	2200	videoangiography
O	2200	2201	.

O	2202	2207	There
O	2208	2212	were
O	2213	2217	four
O	2218	2220	of
O	2221	2224	104
B-Anatomy	2225	2229	eyes
O	2230	2232	in
O	2233	2238	which
B-Diagnostic_tool	2239	2242	ICG
I-Diagnostic_tool	2243	2259	videoangiography
O	2260	2268	revealed
O	2269	2275	poorly
O	2276	2283	defined
B-Characteristic	2284	2299	hypercyanescent
O	2300	2305	areas
O	2306	2310	when
O	2310	2311	,
O	2312	2314	by
B-Diagnostic_tool	2315	2317	FA
O	2317	2318	,
O	2319	2324	there
O	2325	2329	were
O	2330	2334	only
B-Symptom	2335	2341	drusen
O	2342	2344	or
B-Symptom	2345	2353	elevated
I-Symptom	2354	2361	blocked
I-Symptom	2362	2374	fluorescence
O	2374	2375	.

B-Diagnostic_tool	2376	2387	Indocyanine
I-Diagnostic_tool	2388	2393	green
I-Diagnostic_tool	2394	2410	videoangiography
O	2411	2419	revealed
O	2420	2424	only
O	2425	2430	three
B-Anatomy	2431	2435	eyes
O	2436	2440	with
O	2441	2447	poorly
O	2448	2455	defined
B-Characteristic	2456	2472	hypercyanescence
O	2473	2475	of
O	2476	2479	200
O	2480	2486	fellow
B-Anatomy	2487	2491	eyes
O	2492	2494	in
O	2495	2503	patients
O	2504	2508	with
O	2509	2519	unilateral
B-Disease	2520	2523	AMD
O	2523	2524	.

B-Diagnostic_tool	2525	2536	Indocyanine
I-Diagnostic_tool	2537	2542	green
I-Diagnostic_tool	2543	2559	videoangiography
O	2560	2570	correlated
O	2571	2577	fairly
O	2578	2582	well
O	2583	2587	with
B-Diagnostic_tool	2588	2600	stereoscopic
I-Diagnostic_tool	2601	2603	FA
O	2604	2607	for
O	2608	2611	the
O	2612	2620	presence
O	2621	2623	of
B-Symptom	2624	2628	CCNV
O	2629	2631	or
B-Symptom	2632	2637	FVPED
O	2637	2638	,
O	2639	2642	but
O	2643	2653	correlated
O	2654	2660	poorly
O	2661	2665	when
B-Symptom	2666	2670	LLUS
O	2671	2674	was
O	2675	2682	present
O	2682	2683	.

O	2684	2686	In
O	2687	2694	certain
O	2695	2700	cases
O	2701	2706	where
B-Symptom	2707	2710	CNV
O	2711	2714	was
O	2715	2725	associated
O	2726	2730	with
B-Symptom	2731	2735	SPED
O	2736	2738	or
B-Symptom	2739	2746	macular
I-Symptom	2747	2757	hemorrhage
O	2757	2758	,
B-Diagnostic_tool	2759	2762	ICG
I-Diagnostic_tool	2763	2779	videoangiography
O	2780	2792	demonstrated
O	2793	2801	features
O	2802	2805	not
O	2806	2814	apparent
O	2815	2817	on
B-Diagnostic_tool	2818	2820	FA
O	2820	2821	.
